• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection

tetano

Editor, Senior Moderator
PLoS One


. 2025 Jun 11;20(6):e0325923.
doi: 10.1371/journal.pone.0325923. eCollection 2025. Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection

Nikolas Weigl[SUP] 1 [/SUP], Claire Pleimelding[SUP] 2 [/SUP], Leonard Gilberg[SUP] 2 [/SUP], Duc Huynh[SUP] 1 [/SUP], Isabel Brand[SUP] 1 [/SUP], Jan Bruger[SUP] 3 [/SUP], Jonathan Frese[SUP] 3 [/SUP], Tabea M Eser[SUP] 3 4 [/SUP], Mohamed I M Ahmed[SUP] 3 [/SUP], Jessica M Guggenbuehl-Noller[SUP] 2 [/SUP], Renate Stirner[SUP] 2 [/SUP], Michael Hoelscher[SUP] 3 4 5 [/SUP], Michael Pritsch[SUP] 3 5 [/SUP], Christof Geldmacher[SUP] 3 4 5 [/SUP], Sebastian Kobold[SUP] 1 6 7 [/SUP], Julia Roider[SUP] 2 5 [/SUP]; KoCo19-/ORCHESTRA-study group



Affiliations
Free article Abstract

Memory T cells play an important role in mediating long-lasting adaptive immune responses to viral infections, such as SARS-CoV-2. In the context of the latter, much of our current knowledge stems from studies in vaccinated individuals or repeatedly infected individuals. However, limited knowledge is available on these responses in fully naive individuals in German communities. We performed immunophenotyping of a previously naive SARS-CoV-2 cohort in convalescent individuals after asymptomatic to moderate COVID-19. The samples were collected median 250 days post infection during the first wave of the COVID pandemic in Germany (March - May 2020). In this cohort of 174 individuals, we phenotyped different leukocyte cell populations in peripheral blood (B, T and Natural Killer cells). We then assessed the serostatus against the SARS-CoV-2 antigens Nucleocapsid (N) and Spike subunit (S1) with its receptor binding domain (RBD), as these are important correlates of protection, by testing for presence of immunoglobulin G (IgG) antibodies. We also measured IgG antibody responses against the N antigen of the common cold coronaviruses HCoV-OC43, HCoV-HKU1, HCoV-NL63 and HCoV-229E, to determine possible cross-reactivity. In a subset of the cohort (n = 76), we performed intracellular staining assays (ICS) after stimulation with SARS-CoV-2 and HCoV antigens. Key findings are significant differences in frequency of CD4+ memory T cell populations, notably CD4+ TEM and CD4+ TEMRA cells, between the group of SARS-CoV-2 positive individuals and the control group. These differences correlated with cytokine production (TNFα, IFNγ) after stimulation with SARS-CoV-2 peptides, indicating a specific T cell immune response. In conclusion, a clear memory T cell and humoral response can be detected up to 250 days post mild to moderate COVID-19 disease. Our results underline findings reported by others indicating a lasting cellular immune response even in a population which previously had not been exposed to SARS-CoV-2.


 
Back
Top Bottom